골 대사 약물 복용 환자의 MRONJ 위험 인자로의 Implants

키워드

참고문헌 (57)

1. Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update", J Oral Maxillofac Surg, 72(10), pp.1938~1956 (2014)
2. Chadha GK, "Osseointegration of dental implants and osteonecrosis of the jaw in patients treated with bisphosphonate therapy : a systematic review", J Oral Implantol, 39(4), pp.510~520 (2013)
3. S hannon J, "Bisphosphonates and osteonecrosis of the jaw", J Am Geriatr Soc, 59(12), pp.2350~2355 (2011)
4. Al-Sabbagh M, "Effect of Bisphosphonate and Age on Implant Failure as Determined by Patient-Reported Outcomes", J Oral Implantol, 41(6), pp.e287~291 (2015)
5. Wood J, "Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid", J Pharmacol Exp Ther, 302(3), pp.1055~1061 (2002)
6. Otto S, "Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases", Cancer Treat Rev, 69, pp.177~187 (2018)
7. Khosla S, "Bisphosphonate-associated osteonecrosis of the jaw : report of a task force of the American Society for Bone and Mineral Research", J Bone Miner Res, 22(10), pp.1479~1491 (2007)
8. Watts NB, "Invasive Oral Procedures and Events in Postmenopausal Women With Osteoporosis Treated With Denosumab for Up to 10 Years", J Clin Endocrinol Metab, 104(6), pp.2443~2452 (2019)
9. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws AAoO, "American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws", J Oral Maxillofac Surg, 65(3), pp.369~376 (2007)
10. Lazarovici TS, "Bisphosphonate-related osteonecrosis of the jaw associated with dental implants", J Oral Maxillofac Surg, 68(4), pp.790~796 (2010)
11. Limones A, "zoledronic acid : A systematic review and meta-analysis", Med Oral Patol Oral Cir Bucal, 25(3), pp.e326~e336 (2020)
12. Hanley DA, "Denosumab : mechanism of action and clinical outcomes", Int J Clin Pract, 66(12), pp.1139~1146 (2012)
13. Aghaloo TL, "Osteonecrosis of the jaw in a patient on Denosumab", J Oral Maxillofac Surg, 68(5), pp.959~963 (2010)
14. Poxleitner P, "The Prevention of Medication-related Osteonecrosis of the Jaw", Dtsch Arztebl Int, 114(5), pp.63~69 (2017)
15. Saad F, "Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases", Ann Oncol, 23(5), pp.1341~1347 (2012)
16. Roelofs AJ, "Molecular mechanisms of action of bisphosphonates : current status", Clin Cancer Res, 12(20 Pt 2), pp.6222s~6230s (2006)
17. Madrid C, "What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review", Clin Oral Implants Res, 20(Suppl 4), pp.87~95 (2009)
18. Esposito M, "Biological factors contributing to failures of osseointegrated oral implants. (I). Success criteria and epidemiology", Eur J Oral Sci, 106(1), pp.527~551 (1998)
19. Giovannacci I, "Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?", J Craniofac Surg, 27(3), pp.697~701 (2016)
20. Minsk L, "Dental implant outcomes in postmenopausal women undergoing hormone replacement", Compend Contin Educ Dent, 19(9), pp.859~862 (1998)
21. Yajima N, "Influence of Bisphosphonates on Implant Failure Rates and Characteristics of Postmenopausal Woman Mandibular Jawbone", J Oral Implantol, 43(5), pp.345~349 (2017)
22. Cabrales-Salgado RJ, "Mechanical Properties of the Mandible in Postmenopausal Women Under Aledronate Treatment", J Int Acad Periodontol, 22(4), pp.231~235 (2020)
23. Fliefel R, "Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw(BRONJ)with characterization of patients : a systematic review", Int J Oral Maxillofac Surg, 44(5), pp.568~585 (2015)
24. Sher J, "Dental Implant Placement in Patients with a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review", J Oral Implantol (2020)
25. Marx RE, "Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment", J Oral Maxillofac Surg, 65(12), pp.2397~2410 (2007)
26. Jacobsen C, "Osteopathology induced by bisphosphonates and dental implants : clinical observations", Clin Oral Investig, 17(1), pp.167~175 (2013)
27. Marx RE, "Bisphosphonate induced exposed bone (osteonecrosis", osteopetrosis) of the jaws:risk factors, recognition, prevention, and treatment, 2005, pp.63(11), 1567~1575
28. Aljohani S, "What is the effect of anti-resorptive drugs(ARDs)on the development of medication-related osteonecrosis of the jaw(MRONJ)in osteoporosis patients : A systematic review", J Craniomaxillofac Surg, 45(9), pp.1493~1502 (2017)
29. Otto S, "Tooth extraction in patients receiving oral or intravenous bisphosphonate administration:A trigger for BRONJ development?", J Craniomaxillofac Surg, 43(6), pp.847~854 (2015)
30. Kos M, "Bisphosphonates enhance bacterial adhesion and biofilm formation on bone hydroxyapatite", J Craniomaxillofac Surg, 43(6), pp.863~869 (2015)
31. Khan AA, "Diagnosis and management of osteonecrosis of the jaw : a systematic review and international consensus", J Bone Miner Res, 30(1), pp.3~23 (2015)
32. AlDhalaan NA, "Medication-related Osteonecrosis of the Jaw : A Review", Cureus, 12(2), pp.e6944~ (2020)
33. Stavropoulos A, "The effect of antiresorptive drugs on implant therapy : Systematic review and metaanalysis", Clin Oral Implants Res, 29(Suppl 18), pp.54~92 (2018)
34. Martin DC, "Characteristics of implant failures in patients with a history of oral bisphosphonate therapy", J Oral Maxillofac Surg, 68(3), pp.508~514 (2010)
35. Tallarico M, "Dental implants treatment outcomes in patient under active therapy with alendronate : 3-year follow-up results of a multicenter prospective observational study", Clin Oral Implants Res, 27(8), pp.943~949 (2016)
36. Pogrel MA, "Previously successful dental implants can fail when patients commence anti-resorptive therapy-a case series", Int J Oral Maxillofac Surg, 47(2), pp.220~222 (2018)
37. Troeltzsch M, "Clinical features of periimplant medication-related osteonecrosis of the jaw: Is there an association to peri-implantitis?", J Craniomaxillofac Surg, 44(12), pp.1945~1951 (2016)
38. Pichardo SEC, "Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws(MRONJ)", Br J Oral Maxillofac Surg, 58(7), pp.771~776 (2020)
39. Kwon TG, "Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment", Clin Oral Implants Res, 25(5), pp.632~640 (2014)
40. Hoefert S, "Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw : a possible pathogenetic model of symptomatic and nonsymptomatic osteonecrosis of the jaw based on scanning electron microscopy findings", Clin Oral Investig, 14(3), pp.271~284 (2010)
41. Bedogni A, "Oral bisphosphonate-associated osteonecrosis of the jaw after implant surgery : a case report and literature review", J Oral Maxillofac Surg, 68(7), pp.1662~1666 (2010)
42. Marx RE, "A decade of bisphosphonate bone complications : what it has taught us about bone physiology", Int J Oral Maxillofac Implants, 29(2), pp.e247~258 (2014)
43. Grant BT, "Outcomes of placing dental implants in patients taking oral bisphosphonates : a review of 115 cases", J Oral Maxillofac Surg, 66(2), pp.223~230 (2008)
44. Nisi M, "Risk factors influencing BRONJ staging in patients receiving intravenous bisphosphonates : a multivariate analysis", Int J Oral Maxillofac Surg, 44(5), pp.586~591 (2015)
45. Otto S, "Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment", J Craniomaxillofac Surg, 40(4), pp.303~309 (2012)
46. Fehm T, "Bisphosphonate-induced osteonecrosis of the jaw(ONJ) : Incidence and risk factors in patients with breast cancer and gynecological malignancies", Gynecol Oncol, 112(3), pp.605~609 (2009)
47. Papadakis I, "Success rate and safety of dental implantology in patients treated with antiresorptive medication: A systematic review", J Oral Implantol (2020)
48. Mozzati M, "Failure risk estimates after dental implants placement associated with plasma rich in growth factor-Endoret in osteoporotic women under bisphosphonate therapy", J Craniofac Surg, 26(3), pp.749~755 (2015)
49. de-Freitas NR, "Bisphosphonate treatment and dental implants : A systematic review", Med Oral Patol Oral Cir Bucal, 21(5), pp.e644~651 (2016)
50. Kasai T, "The prognosis for dental implants placed in patients taking oral bisphosphonates", J Calif Dent Assoc, 37(1), pp.39~42 (2009)
51. Tallarico M, "Clinical and radiological outcomes of 1-versus 2-stage implant placement : 1-year results of a randomised clinical trial", Eur J Oral Implantol, 4(1), pp.13~20 (2011)
52. American Dental Association Council on Scientific A, "Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations", J Am Dent Assoc, 137(8), pp.1144~1150 (2006)
53. Yip JK, "Association between oral bisphosphonate use and dental implant failure among middle-aged women", J Clin Periodontol, 39(4), pp.408~414 (2012)
54. Markiewicz MR, "Bisphosphonate-associated osteonecrosis of the jaws : a review of current knowledge", J Am Dent Assoc, 136(12), pp.1669~1674 (2005)
55. Kumar MN, "Survival of dental implants in bisphosphonate users versus non-users : a systematic review", Eur J Prosthodont Restor Dent, 20(4), pp.159~162 (2012)
56. Sim Ie W, "Declining Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Cancer", J Clin Endocrinol Metab, 100(10), pp.3887~3893 (2015)
57. Kim JY, "Effects of anti-resorptive drugs on implant survival and peri-implantitis in patients with existing osseointegrated dental implants : a retrospective cohort study", Osteoporos Int, 31(9), pp.1749~1758 (2020)

관련 논문AI추천